Want to follow suspected Ebola cases? Here’s the place: SHTF Dashboard

Men enter the Arlington Convention Center to receive their H1N1 flu vaccinations in Arlington, Texas November 24, 2009. Credit: Reuters/Jessica Rinaldi From Reuters: Doctors and minorities still have a dangerous mistrust of vaccines that became painfully clear during the H1N1 swine flu pandemic, U.S. Health and Human Services Secretary Kathleen Sebelius said on Monday… In…

The following excerpts from today’s NY Times article point to serious failures of data collection, analysis, and commitment to safety at FDA.  The failures follow lax, politically-driven regulations, which allow products to be licensed without data if they are substantially like other licensed products.  There is no good guideline for how alike the products must…

From the WaPo we learn there is a shortage of monoclonal antibodies, so the feds will take over distribution.  Hmm.  We don’t know anything about long-term side effects of monoclonals. Monoclonal antibodies are an effective and very expensive product if used in the first week of illness–just like hydroxychloroquine, which the feds (and most states) have…

See Brad Friedman’s piece at The Guardian, UK, and this Washington Post Editorial Holes in the Anthrax Case? The nation and the FBI would benefit from an independent review of the investigation. Saturday, August 9, 2008; A14 ON WEDNESDAY, the federal government made public much of its case against accused anthrax killer Bruce E. Ivins….

My recent talk for the National Vaccine Information Center’s Fifth International Conference goes into the sorry history of this very sketchy company, from its founding in 1998 to the present. It could also be titled:  How Taxpayers Made the Anthrax Vaccine Manufacturer Very, Very Rich from Unused Biowarfare Vaccines and Drug Overdoses. What a business…

Virus Res. 2014 Jun 12;189C:254-261. doi: 10.1016/j.virusres.2014.06.001.  A highly immunogenic fragment derived from Zaire Ebola virus glycoprotein elicits effective neutralizing antibody.  Wang Y1, Liu Z1, Dai Q2. In order to produce polyvalent vaccines based on single rVSV vector, we investigated the immunogenicity, antibody neutralizing activity, and antigenic determinant domain of Zaire Ebola‘s fragment MFL (aa 393-556) that contains furin…